Nervius (Pramipexole Dihydrochloride Monohydrate)

Pramipexole works by selectively stimulating dopamine D2 and D3 receptors in the brain. This activation mimics the action of dopamine, enhancing neurotransmission in pathways that control movement and sensory perception, thereby compensating for the dopamine deficiency seen in Parkinsonian disorders and restless legs syndrome.

The appropriate dose of Nervius is individualized. A qualified prescriber determines the starting dose and any subsequent titration based on the patient’s clinical condition, age, renal function and response to therapy.

Safety data for pramipexole during pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by the treating physician.

To order Nervius, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

The primary alternative to pramipexole is levodopa, which directly replaces dopamine. Pramipexole, as a dopamine agonist, stimulates dopamine receptors without requiring conversion, offering smoother symptom control and a lower risk of motor fluctuations, though it may have a higher incidence of impulse‑control issues.

Nervius tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct light, and ensure they are out of reach of children.

Nervius is taken orally. Swallow the tablet whole with a glass of water, preferably with food to reduce gastrointestinal upset. Follow the prescriber’s instructions regarding timing and any dose adjustments.

Serious risks include the development of hallucinations, impulse‑control disorders such as compulsive gambling or shopping, and sudden onset of sleep episodes. Patients should report any unusual thoughts, behaviors or unexpected sleepiness to their healthcare provider promptly.

Nervius should be avoided in individuals with known hypersensitivity to pramipexole or any of its excipients, in patients with severe renal impairment unless dose‑adjusted, and in those with a history of uncontrolled psychiatric illness where dopamine agonists could exacerbate symptoms.